Prologue Medicines

Prologue Medicines is creating powerful new medicines by unlocking the therapeutic potential of viral proteins. Viral proteins have evolved with humans for millions of years and have been optimized to modulate human biology. Powered by the largest known database of viral protein structures, Prologue’s DELVE™ machine learning platform systematically identifies the proteins that precisely regulate human biology, uncovers new therapeutic targets and programs transformative features into novel therapeutics.